Qingdao NovelBeam Technology Co. Ltd. A - Asset Resilience Ratio
Qingdao NovelBeam Technology Co. Ltd. A (688677) has an Asset Resilience Ratio of 6.86% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688677 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2023)
This chart shows how Qingdao NovelBeam Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688677 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Qingdao NovelBeam Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Qingdao NovelBeam Technology Co. Ltd. A (688677) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥103.84 Million | 6.86% |
| Total Liquid Assets | CN¥103.84 Million | 6.86% |
Asset Resilience Insights
- Limited Liquidity: Qingdao NovelBeam Technology Co. Ltd. A maintains only 6.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Qingdao NovelBeam Technology Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Qingdao NovelBeam Technology Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410 |
Medical Instruments & Supplies | 38.45% |
|
Hangzhou Alltest Biotech Co. Ltd. A
SHG:688606 |
Medical Instruments & Supplies | 11.88% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
Annual Asset Resilience Ratio for Qingdao NovelBeam Technology Co. Ltd. A (2023–2023)
The table below shows the annual Asset Resilience Ratio data for Qingdao NovelBeam Technology Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 2.76% | CN¥38.45 Million ≈ $5.63 Million |
CN¥1.39 Billion ≈ $204.11 Million |
-- |
About Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more